StockData
Pulmonx Corp logo

Pulmonx Corp (LUNG) stock

LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/3040% below fair value
$2.86−0.14 (-4.67%)

Close on Nov 13, 2026Market cap $122.83MP/E –Yield –

Pulmonx gross margin

Gross margin is gross profit as a percentage of revenue.

Pulmonx's gross margin for the twelve months ending Sep 30, 2026 was 77.4%. For fiscal 2025 it was 74.2%, against 74.0% the year before. The highest annual figure on record is 74.3% in fiscal 2022.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202574.2%+0.2
FY2024Dec 31, 202474.0%+0.1
FY2023Dec 31, 202373.9%−0.4
FY2022Dec 31, 202274.3%+0.7
FY2021Dec 31, 202173.6%+8.8
FY2020Dec 31, 202064.8%−4.0
FY2019Dec 31, 201968.8%+7.3
FY2018Dec 31, 201861.4%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202676.2%+1.5
Q2 FY2026Jun 30, 202678.0%+5.9
Q1 FY2026Mar 31, 202677.9%+5.4
Q4 FY2025Dec 31, 202577.6%+3.6
Q3 FY2025Sep 30, 202574.7%+0.9
Q2 FY2025Jun 30, 202572.1%−1.5
Q1 FY2025Mar 31, 202572.5%−2.2
Q4 FY2024Dec 31, 202474.0%−0.7
Q3 FY2024Sep 30, 202473.7%−0.0
Q2 FY2024Jun 30, 202473.7%−0.4
Q1 FY2024Mar 31, 202474.7%+1.8
Q4 FY2023Dec 31, 202374.7%+2.2
Q3 FY2023Sep 30, 202373.7%−1.4
Q2 FY2023Jun 30, 202374.1%−0.6
Q1 FY2023Mar 31, 202372.9%−2.4
Q4 FY2022Dec 31, 202272.5%−2.3
Q3 FY2022Sep 30, 202275.2%+1.7
Q2 FY2022Jun 30, 202274.7%+0.7
Q1 FY2022Mar 31, 202275.2%+3.7
Q4 FY2021Dec 31, 202174.8%+2.8
Q3 FY2021Sep 30, 202173.4%+3.1
Q2 FY2021Jun 30, 202174.0%+46.4
Q1 FY2021Mar 31, 202171.5%+6.0
Q4 FY2020Dec 31, 202072.0%+1.1
Q3 FY2020Sep 30, 202070.3%−0.1
Q2 FY2020Jun 30, 202027.6%−39.7
Q1 FY2020Mar 31, 202065.6%+1.2
Q4 FY2019Dec 31, 201970.9%–
Q3 FY2019Sep 30, 201970.4%–
Q2 FY2019Jun 30, 201967.2%–
Q1 FY2019Mar 31, 201964.3%–

More Pulmonx figures

See a number that looks wrong?